
Political Theater's The Transition: Richmond is Biden's gain and Congress' loss
President-elect Joe Biden has poached the first member of Congress for his administration — Louisiana Democrat Cedric Richmond. The lawmaker will become a senior adviser to the president and director ...
17 Marras 202013min

Aviation: A big day for Boeing
The House this week is scheduled to take up a bill revamping how the FAA certifies aircraft, and the Senate Commerce Committee will mark up its version on Wednesday. CQ Roll Call's Jessica Wehrman rep...
17 Marras 20202min

Tech: Is it time for social media platforms to be legally responsible for their content?
Big Tech — including Facebook and Twitter — are in Congress' crosshairs. Many lawmakers say that these companies should no longer be shielded by a nearly 25 year old law that keeps them from taking re...
17 Marras 20203min

Budget deep dive: COVID-19 relief and omnibus spending bill face long odds
The odds are seemingly against a robust COVID-19 relief package and omnibus appropriations bill passing during the lame-duck session. What does this mean for fiscal 2021? CQ Roll Call’s Jennifer Shutt...
17 Marras 202018min

Fintech Beat: Fintech's free will
Jenny Xia Spradling, the co-founder of Free Will, recounts her journey, why she walked away from her first startup, and how her new big venture has enabled over $1 billion of donations to nonprofits L...
17 Marras 202027min

Political Theater's The Transition: "More people may die"
President-elect Joe Biden says that "more people may die" if President Donald Trump doesn't soon share what the current plans are to combat COVID-19 and distribute vaccines. Also, a first look at who ...
17 Marras 202014min

Immigration: Some Trump immigration policies are in peril
A federal judge over the weekend ruled that acting Homeland Secretary chief Chad Wolf was improperly installed so lacked the authority to block new DACA application. CQ Roll Call's Camila DeChalus rep...
16 Marras 20202min

Health: Big strides on vaccines to fight COVID-19
A second company Moderna, follows in Pfizer's footsteps and announces that its vaccine trials to fight the coronavirus were over 94 percent effective. CQ Roll Call's Emily Kopp has more about what thi...
16 Marras 20203min



















